Suppr超能文献

注入的胰岛素样生长因子-I/胰岛素样生长因子结合蛋白-3复合物导致胰岛素样生长因子-I在大鼠肾脏中的肾小球定位。

Infused IGF-I/IGFBP-3 complex causes glomerular localization of IGF-I in the rat kidney.

作者信息

Sandra A, Boes M, Dake B L, Stokes J B, Bar R S

机构信息

Department of Internal Medicine, Diabetes and Endocrinology Research Center, Veterans Administration Medical Center, The University of Iowa, Iowa City, Iowa 52246, USA.

出版信息

Am J Physiol. 1998 Jul;275(1):E32-7. doi: 10.1152/ajpendo.1998.275.1.E32.

Abstract

Insulin-like growth factor I (IGF-I) increases renal blood flow, glomerular filtration rate (GFR), and proximal tubule reabsorption of phosphate in humans and rodents. The biological effects of IGF-I are likely to be influenced by cellular localization of IGF-I within the kidney. We therefore tested whether the renal localization of infused IGF-I could be altered if given with selected IGF-binding proteins (IGFBPs). Rats were treated with intravenous injections of 125I-labeled IGF-I, 125I-IGFBP-3, or 125I-IGFBP-4 alone or with complexes of 125I-IGF-I and IGFBP-3 or IGFBP-4. The cellular localization of IGF and the IGFBP within the kidney was then determined. 125I-IGF-I, 125I-IGFBP-4, and 125I-IGF-I/IGFBP-4 complexes were found almost exclusively in vacuolar structures (endosomes) of proximal renal tubules. In contrast, about one-third of renal 125I-IGFBP-3 and 125I-IGF-I/IGFBP-3 was localized to glomeruli. When 125I-IGF-I was given alone, 3% was found in glomeruli and 89% in proximal tubules. When given as 125I-IGF-I/IGFBP-3, 29% was in glomeruli and 65% in proximal tubules. We conclude that the cellular localization of IGF-I within the kidney can be directed to glomerular elements if the IGF-I is given with IGFBP-3.

摘要

胰岛素样生长因子I(IGF-I)可增加人和啮齿动物的肾血流量、肾小球滤过率(GFR)以及近端肾小管对磷酸盐的重吸收。IGF-I的生物学效应可能受其在肾脏内的细胞定位影响。因此,我们测试了如果给予特定的胰岛素样生长因子结合蛋白(IGFBPs),注入的IGF-I在肾脏中的定位是否会改变。给大鼠静脉注射单独的125I标记的IGF-I、125I-IGFBP-3或125I-IGFBP-4,或125I-IGF-I与IGFBP-3或IGFBP-4的复合物。然后确定IGF和IGFBP在肾脏内的细胞定位。发现125I-IGF-I、125I-IGFBP-4和125I-IGF-I/IGFBP-4复合物几乎完全存在于近端肾小管的液泡结构(内体)中。相比之下,肾脏中约三分之一的125I-IGFBP-3和125I-IGF-I/IGFBP-3定位于肾小球。当单独给予125I-IGF-I时,3%存在于肾小球,89%存在于近端肾小管。当以125I-IGF-I/IGFBP-3形式给予时,29%存在于肾小球,65%存在于近端肾小管。我们得出结论,如果IGF-I与IGFBP-3一起给予,则其在肾脏内的细胞定位可导向肾小球成分。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验